Outset Medical
- Home
- Companies
- Outset Medical
- Articles
- Early Experience with a Novel ...
Early Experience with a Novel Hemodialysis System used for PIRRT Demonstrates Clinical Management at Lower Cost than CRRT and IHD - Case Study
May. 2, 2021- By: Sevag Demirjian;Matthew Layne;Glenn M Chertow;Luis Alvarez
Courtesy ofOutset Medical
The need for providing dialysis to patients in the ICU has increased overtime. Delivery of this care is challenging to health care systems (HCS) both in costs and logistics
Most popular related searches
hemodialysis system
critical patient
healthcare system
clinic management
clinical management
hemodialysis
health system
hemodynamic
patient testing
dialysis dose
- All 79 treatments were tailored to specific patient need with no specific guidance on prescription
- In 7 cases treatment was terminated early due to patients needs for testing, procedures or machine availability
- 58 (82%) of treatments achieved their target dose of dialysis and UF
- Causes of early termination were related to access issues, clotting, hemodynamic instability or other related factors
- The cost of PIRRT with Tablo was found to be significantly lower than both CRRT and IHD with a traditional dialysis machine
- Prospective pilot study of the Tablo® Hemodialysis System in 37 critically ill patients deemed appropriate by the physician with no specific inclusion/exclusion criteria
- 79 treatments were performed ranging from 4-12 hours using a QB between 200-300 ml/min and QD between 100-300 ml/min while recording treatment results and staffing and supply costs